Cloud-based electronic lab notebook with integrated inventory management, project management, and FDA 21 CFR Part 11 compliance for pharmaceutical and biotech research.
SciNote is a cloud-based Electronic Lab Notebook (ELN) platform that serves as an all-in-one lab digitalization solution for research data management. The system organizes work through a hierarchical projects/experiments/tasks structure that mirrors how research actually occurs in pharmaceutical and biotech laboratories.
The platform integrates lab inventory management, protocol management, and compliance tools into a single system. SciNote provides a searchable research database with support for multiple file formats, hyperlinked results, and smart annotation capabilities for cross-referencing inventory items, protocols, and team members.
SciNote serves pharmaceutical, biotech, diagnostics labs, CROs, CDOs, CDMOs, medical devices, and academic research institutions globally. SciNote states the platform is trusted by FDA, USDA, and over 100,000 scientists in 100+ countries. Notable clients include BD, Qiagen, Agilent, and Aragen.
The platform addresses regulated environment requirements through FDA 21 CFR Part 11 compliance features including electronic signatures, audit trails, timestamps, and activity logs. SciNote is ISO 27001 certified and supports GLP/GMP standards with appropriate access controls and security measures. Users report averaging 9 hours per week in time savings through faster data retrieval, process replication, and streamlined reporting.
SciNote is deployed as a cloud-based SaaS solution with FedRAMP authorization in progress for government and regulated environments. The platform is accessible via web browsers and native mobile applications for iOS and Android devices.
The system provides a RESTful API for custom integrations and automated data synchronization. Native integrations include Microsoft Office (Word, Excel, PowerPoint), protocols.io for protocol management, Quartzy for procurement, and label makers (FLUICS Print, Zebra printers). The platform partners with Ganymede for instrument and application connectivity. SciNote Edit feature enables desktop application editing of attached files.
Security architecture includes data encryption, multi-layer authentication, unique user logins, ISO 27001 certification, GDPR compliance, and backup systems. The platform provides full export functionality that exports all electronic data in human-readable format with attachments organized in folders. Access is controlled through user roles and permissions with time-stamped audit trails that are non-editable and non-deletable.
SciNote offers subscription-based pricing with two main tiers: Industry and Academia plans. A free version exists for individual users. Premium plans include dedicated Customer Success Manager and no additional onboarding or training costs.
Specific pricing not publicly disclosed. Trial options and demo availability mentioned but specific free trial duration not specified.
SciNote's homepage states a 9.5/10 user satisfaction rating from 133 reviews. That figure is SciNote's own, not a G2 score; the G2 product page carries 4.2/5 across 303 reviews. SciNote also states G2 Leader designation maintained for 5 consecutive years. Users report ROI benefits averaging 9 hours per week in time savings through faster data retrieval, process replication, and streamlined reporting.
SciNote implementation includes specialist-guided setup. No additional onboarding or training costs are disclosed. Premium plans include a dedicated Customer Success Manager (CSM) for ongoing support and optimisation.
Training resources are provided through multiple channels including YouTube tutorials, comprehensive knowledge base articles, and SciNote Academy courses. The platform supports data migration through Excel import/export functionality for inventory data and API integration capabilities for automated data transfer from legacy systems.
Cloud-based deployment minimises infrastructure requirements and implementation complexity. SciNote markets the interface as reducing the administrative burden of regulatory compliance while maintaining thorough documentation capabilities. Implementation partners and consulting services availability are undisclosed.
Anonymous feedback from pharmaceutical professionals using this solution
4.2 out of 5
Based on 303 verified reviews
Vendor case studies and testimonials describe users appreciating that SciNote makes documentation easy and supports a good documentation culture, with an interface SciNote markets as reducing administrative burden for lab staff. Creation of a searchable database with significant time savings is frequently mentioned, with users reporting average savings of 9 hours per week. Organisations switching from paper or older systems describe the transition as "a truly positive change, bringing our workflow up to speed with the digital age." Quality management teams are able to focus only on the documentation they need to review and approve, minimising administrative overhead. Customer service is described as "Fast, competent, friendly. Always solved my problems." Users note that compliance depends on organisational processes, and describe SciNote as providing the framework and tools for meeting FDA 21 CFR Part 11, GLP, and GMP requirements.
SciNote's website surfaces only positive testimonials and case studies, including from customers NEUWAY Pharma, Contera Pharma, Ingenza, and Dynamic Code. No negative user feedback is published there. SciNote states that ELN software itself cannot be certified as GxP compliant: it can only support laboratories in meeting requirements. GxP compliance focuses on how diligently an organisation implements and handles its own processes and procedural controls. SciNote describes compliance as a complex, resource-consuming process that is not limited to buying and installing compliant software: the entire electronic system for record-keeping needs verification.
Share your experience with SciNote ELN anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section